Emtricitabine Completed Phase 3 Trials for HIV Risk Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02998320Evaluation of Compliance With Treatment by Genvoya in HIV Post-exposure Prophylaxis